People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

7.58USD
24 May 2013
Price Change (% chg)

$-0.06 (-0.79%)
Prev Close
$7.64
Open
$7.63
Day's High
$7.67
Day's Low
$7.40
Volume
482,454
Avg. Vol
1,022,199
52-wk High
$11.36
52-wk Low
$5.42

Search Stocks

Frashier, Gary 

Brief Biography

Mr. Gary E. Frashier serves as Independent Director of Achillion Pharmaceuticals, Inc., since March 2008. He currently serves as chair of the company's Compensation Committee and as a member of the company's Nominating and Corporate Governance Committee. Mr. Frashier, through his company Management Associates, has been a strategic consultant to emerging growth companies in the life sciences field since 2000. From 1990 until September 1998, he served as Chief Executive Officer of OSI Pharmaceuticals, Inc., a biotechnology company, and from January 1997 until September 2000, as its Chairman of the Board. From 1987 until 1990, he served as President and CEO of Genex Corporation, a protein engineering company, and from 1984 until 1987, as Chairman and CEO of Continental Water Systems, Inc., a manufacturer and marketer of equipment to produce high purity water used by the pharmaceutical, medical, electronics and research industries. Mr. Frashier also served as Executive Vice President of Millipore Corporation, a provider of products and services to biopharmaceutical, manufacturing, clinical, analytical and research laboratories, and as President of Millipore’s Waters Associates subsidiary.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

David Scheer

--

Michael Kishbauch

1,422,900

Mary Fenton

817,637

Gautam Shah

827,612

Joseph Truitt

976,868

Milind Deshpande

1,067,720
As Of 30 Dec 2011
Search Stocks